55 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →
Latent Space 18 hours ago 33
Leash Bio’s Ian Quigley discussed how Leash’s DNA Encoded Libraries enable clean, reproducible protein–small molecule binding data and how those results became “lab-in-the-loop” simulations for agent-based scientific reasoning. The team built an agent sandbox that searches among 6.5M molecules with a budget of 100. Minos has since matured into a released preprint, blog, and open dataset.
Ars Technica 21 hours ago 26
Researchers used AI-based protein design tools to redesign proteases by keeping the catalytic cores of two types while replacing the rest of each protein.
The daily briefing
TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.
TLDRocket
15 October 2026
Anthropic’s IPO momentum dominated today’s AI news, and the details read like a pitch built for CFOs, not just researchers. The company told investors its third-quarter revenue hit $16.8 billion, up about 46% quarter over quarter and nearly 50% in the story’s framing, putting it on a clear path toward public-market scrutiny. Crucially for the valuation talk, distillation—how labs compress and reuse model knowledge—contributed only 5% to 7% of revenue before being “cut back materially” in Q3, shifting the mix away from spending and dependencies that other labs leaned on. An early backer’s market-odds math expects shares priced around $1.8 trillion with a trading value of $2.3 to $2.4 trillion, even comparing that jump to SpaceX’s roughly $2.1 trillion opening-day market cap.
Read the full briefing →